Radoslaw Kazmierski | Medical Hypotheses | Medical Hypothesis Award

Published on by Research Hypothesis

Prof. Dr. Radoslaw Kazmierski | Medical Hypotheses | Medical Hypothesis Award

Professor, University of Zielona Gora, Poland

Prof. Dr. Radoslaw Kazmierski is a distinguished researcher whose expertise lies in neurology, stroke medicine, and cerebrovascular disorders. He has contributed significantly to advancing knowledge in stroke prevention, diagnosis, and treatment through his clinical and translational research. He holds a Ph.D. in medicine with specialization in neurological sciences, which has shaped his academic and research pursuits. Prof. Dr. Radoslaw Kazmierski has actively collaborated on international research projects focusing on stroke risk stratification and cognitive impairment, bringing a global perspective to his work. He has authored 49 documents, accumulating 781 citations with an h-index of 14, demonstrating the academic impact and relevance of his research within the medical community. His publication portfolio includes papers in reputed journals indexed in Scopus and other high-impact platforms, making a substantial contribution to evidence-based medicine. Prof. Dr. Radoslaw Kazmierski has also engaged in leadership roles within academic and clinical research settings, mentoring young researchers and guiding clinical trials. He has been associated with professional memberships in neurology associations and continues to contribute to advancing stroke awareness and patient care standards. His work bridges academia, clinical application, and community health initiatives, making him a valuable contributor to global neurological research.

Profile:  Scopus | ORCID

Featured Publications

  1. Short-term outcome after ischemic stroke and 24-h blood pressure variability: association and predictors — 2021; cited by multiple studies as a key predictor model.

  2. Serum Paraoxonase/Arylesterase Activity Affects Outcome in Ischemic Stroke Patients — 2011; widely cited in studies of redox biomarkers and stroke prognosis.

  3. Zaburzenia mowy i języka u pacjentów po przebytym udarze mózgu. Studium epidemiologiczne — 2022; epidemiological study of speech and language disorders post-stroke; though newer, it contributes to functional outcomes research.